Prestige Consumer Healthcare Inc. Overview
Pro stress-test →Prestige Consumer Healthcare develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in North America, Australia, and internationally through two segments: North American OTC Healthcare and International OTC Healthcare. The company owns iconic brands like Dramamine, Fleet, Gaviscon, Monistat, and Summer's Eve, reaching consumers through mass merchandisers, drug stores, dollar stores, and e-commerce channels.
Strategic Profile
Pro stress-test →In fiscal year 2025, PBH's revenue was $1.14 billion, an increase of 1.10% compared to the previous year. According to 5 analysts, the average rating for PBH stock is "Buy" with a 12-month stock price target of $85.4, representing a 27.86% upside from current levels. The company's competitive advantage lies in its diversified portfolio of trusted OTC healthcare brands with established distribution networks.
Competitive Landscape
Pro stress-test →Prestige competes in the OTC consumer healthcare market against companies like Church & Dwight (Arm & Hammer), Reckitt Benckiser, and Procter & Gamble (Vicks). The company differentiates through its diversified portfolio of established brands with strong consumer recognition and efficient distribution networks across retail and e-commerce channels.
Industry Context
Prestige Consumer Healthcare Inc. operates in Over-the-Counter (OTC) Healthcare and Consumer Healthcare Products.
Key facts
Founded: 1996 · Headquarters: Tarrytown, New York · Revenue: $1.14B · Market cap: $2.97B